In this post, I link to and excerpt from the Expert Consensus Decision Pathway 2020 ACC Expert Consensus Decision Pathway on Management of Bleeding in Patients on Oral Anticoagulants [Full Text HTML] [Full Text PDF]. J Am Coll Cardiol. 2020 Aug, 76 (5) 594–622.
Here are excerpts:
Text
Text
Text
Text
Text
Text
Text
Text
Text
Text
Text
Text
6 Discussion and Implication of Pathway
The primary objective of this ECDP is to provide a clinically applicable, easily referenced, conceptual framework to support clinical decision making while caring for patients with bleeding complications during OAC therapy. The writing committee considered patients taking anticoagulant therapy for any indication in order to broaden the potential clinical use and impact of the ECDP. Whenever possible, recommendations are based on quantitative evidence from clinical research. However, large gaps in knowledge exist, and therefore, so much of what clinicians do to care for these patients is based on limited information. It is anticipated that as the population continues to age, more people will be treated with OACs. As more evidence is generated from ongoing research and clinical practice, further refinement to this ECDP will be needed.
